Optimization of trans-Splicing for Huntington's Disease RNA Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimization of trans-Splicing for Huntington's Disease RNA Therapy
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-10
DOI
10.3389/fnins.2017.00544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hoffnung für Huntington-Patienten – erste klinische Gene-Silencing-Studie
- (2017) Jens D. Rollnik FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
- (2017) Nivya Kolli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Huntingtin Inclusions Trigger Cellular Quiescence, Deactivate Apoptosis, and Lead to Delayed Necrosis
- (2017) Yasmin M. Ramdzan et al. Cell Reports
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
- (2016) Benjamin E Deverman et al. NATURE BIOTECHNOLOGY
- Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
- (2016) Guohao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Huntington's Paradox
- (2016) Chiara Zuccato et al. SCIENTIFIC AMERICAN
- Targeted genome engineering using designer nucleases: State of the art and practical guidance for application in human pluripotent stem cells
- (2016) Sylvia Merkert et al. Stem Cell Research
- mRNAtrans -splicing in gene therapy for genetic diseases
- (2016) Adeline Berger et al. Wiley Interdisciplinary Reviews-RNA
- CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
- (2016) Weili Yang et al. Frontiers in Molecular Neuroscience
- Glycation potentiates neurodegeneration in models of Huntington’s disease
- (2016) Hugo Vicente Miranda et al. Scientific Reports
- HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity
- (2015) Virginia B. Mattis et al. HUMAN MOLECULAR GENETICS
- Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia
- (2015) Megan S. Keiser et al. HUMAN MOLECULAR GENETICS
- RAN Translation in Huntington Disease
- (2015) Monica Bañez-Coronel et al. NEURON
- Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington’s Disease Neural Stem Cells
- (2015) Karen L. Ring et al. Stem Cell Reports
- Peptide-Based Therapeutic Approaches for Treatment of the Polyglutamine Diseases
- (2014) Toshihide Takeuchi et al. CURRENT MEDICINAL CHEMISTRY
- Cis -splicing and Translation of the Pre- Trans -splicing Molecule Combine With Efficiency in Spliceosome-mediated RNA Trans -splicing
- (2014) François Monjaret et al. MOLECULAR THERAPY
- In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides
- (2014) Amber L Southwell et al. MOLECULAR THERAPY
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease
- (2014) X.-H. Lu et al. Science Translational Medicine
- Integrative transcriptome sequencing identifies trans-splicing events with important roles in human embryonic stem cell pluripotency
- (2013) C.-S. Wu et al. GENOME RESEARCH
- Dystrophin rescue by trans -splicing: a strategy for DMD genotypes not eligible for exon skipping approaches
- (2013) Stéphanie Lorain et al. NUCLEIC ACIDS RESEARCH
- Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
- (2013) Michael E. Østergaard et al. NUCLEIC ACIDS RESEARCH
- EZ spheres: A stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs
- (2013) Allison D. Ebert et al. Stem Cell Research
- Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress
- (2013) Julia Leitman et al. Nature Communications
- SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
- (2013) Jacqueline Gire O’Rourke et al. Cell Reports
- Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
- (2012) The HD iPSC Consortium Cell Stem Cell
- Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
- (2012) Mahru C. An et al. Cell Stem Cell
- Replacement of huntingtin exon 1 by trans-splicing
- (2012) Hansjörg Rindt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis
- (2012) Tamara Pringsheim et al. MOVEMENT DISORDERS
- “Huntingtin Holiday”: Progress toward an Antisense Therapy for Huntington's Disease
- (2012) Xiao-Hong Lu et al. NEURON
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity
- (2012) Mónica Bañez-Coronel et al. PLoS Genetics
- Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
- (2011) Steven J. Gray et al. HUMAN GENE THERAPY
- Energy deficit in Huntington disease: why it matters
- (2011) Fanny Mochel et al. JOURNAL OF CLINICAL INVESTIGATION
- Optimization of SMN Trans-Splicing Through the Analysis of SMN Introns
- (2011) Monir Shababi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Identification of cis-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human BDNF Gene
- (2011) P. Pruunsild et al. JOURNAL OF NEUROSCIENCE
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
- (2011) Jodi L McBride et al. MOLECULAR THERAPY
- Identifying polyglutamine protein species in situ that best predict neurodegeneration
- (2011) Jason Miller et al. Nature Chemical Biology
- Is Huntington disease a developmental disorder?
- (2010) Sandrine Humbert EMBO REPORTS
- Combination of SMN Trans-Splicing and a Neurotrophic Factor Increases the Life Span and Body Mass in a Severe Model of Spinal Muscular Atrophy
- (2010) Monir Shababi et al. HUMAN GENE THERAPY
- K14 mRNA reprogramming for dominant epidermolysis bullosa simplex
- (2010) Verena Wally et al. HUMAN MOLECULAR GENETICS
- Functional Correction of Type VII Collagen Expression in Dystrophic Epidermolysis Bullosa
- (2010) Eva M. Murauer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy
- (2010) T. H. Coady et al. JOURNAL OF NEUROSCIENCE
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells
- (2009) Tamara Ratovitski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- Rapid Eye Movement Sleep Disturbances in Huntington Disease
- (2008) Isabelle Arnulf et al. ARCHIVES OF NEUROLOGY
- Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity
- (2008) H. D. Rosas et al. BRAIN
- Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing
- (2008) H Y Chen et al. GENE THERAPY
- Transient Immunomodulation Allows Repeated Injections of AAV1 and Correction of Muscular Dystrophy in Multiple Muscles
- (2008) Stéphanie Lorain et al. MOLECULAR THERAPY
- Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts
- (2008) Tristan H. Coady et al. PLoS One
- 5′ Trans-Splicing Repair of the PLEC1 Gene
- (2007) Verena Wally et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started